Endo secures recognition in Canada after patent set-back in US appeal court

Two Canadian affiliates of Irish-registered pharmaceutical group Endo have obtained recognition of the group’s New York bankruptcy proceedings in Toronto as it lost an appeal in the US to block a generic version of its best-selling drug.

Unlock unlimited access to all Global Restructuring Review content